At a Glance
Dosage
Only in DOI
oral
| Level | Dose |
|---|---|
| Threshold | 0.5 mg |
| Light | 0.5–1 mg |
| Common | 1–2 mg |
| Strong | 2–3 mg |
| Heavy | 3 mg |
Only in 25B-NBOMe
insufflated
| Level | Dose |
|---|---|
| Threshold | 25 µg |
| Light | 50–200 µg |
| Common | 200–350 µg |
| Strong | 350–500 |
Duration
Only in DOI
oral
Onset
Come Up
Onset: 1 hrs – 2 hrsCome Up: 1.5 hrs – 3 hrs
Total: 16 hrs – 24 hrs
Only in 25B-NBOMe
sublingual
Peak
Offset
Afterglow
Onset: 20 min – 40 minCome Up: 30 min – 1.5 hrsPeak: 4 hrs – 6 hrs 2 hrs – 4 hrs
Effects
Safety
Interaction: DOI + 25B-NBOMe
No direct interaction data available between these substances. This does not mean the combination is safe.
DOI — Dangerous Interactions
No dangerous interactions recorded.
25B-NBOMe — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between DOI and 25B-NBOMe?
DOI is classified as a Psychedelic (Substituted amphetamines) while 25B-NBOMe is classified as a Psychedelic (Substituted phenethylamines). They share 32 effects in common, with 21 effects unique to DOI and 5 unique to 25B-NBOMe.
Is it safe to combine DOI and 25B-NBOMe?
There is no direct interaction data available for combining DOI and 25B-NBOMe. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, DOI or 25B-NBOMe?
DOI and 25B-NBOMe are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.